Orthopaedic firm Cardo Medical is to divest its joint arthroplasty business to sports science specialist Arthrex.
Orthopaedic firm Cardo Medical is to divest its joint arthroplasty business to sports science specialist Arthrex.
The divested unit consists of Cardo's hip and knee assets, including the Align 360 range of unicompartmental, patello-femoral and total knee systems, as well as the Press Fit total...
TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.
The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.
Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.
